An interesting investigation that assesses the beneficial effects of high-dose atorvastatin in preventing contrast-induced nephropathy in patients receiving non-urgent cardiac catheterization.

**************************************

Estimated Time to View: 50 minutes
Title: Statin use for renoprotection against contrast-induced nephropathy
Author: Sarath Kolluru, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2011
Date Created: 2011
Revisions: None Indicated
Disclaimers: None
Resource Type: Video
Other: Presented at ECU Nephrology Journal Club on 11/15/11
Recommend to a Colleague/Friend

**************************************

LEARNING OPTIONS:

To view the interactive video, click here
To view this video using an iPad or iPhone, see below



Transparent Peer Review

GD Star Rating
loading...


To learn more about our 6-point transparent peer review system, click here



Statin use for renoprotection against contrast-induced nephropathy - the ARMYDA-CIN trial, 1.0 out of 10 based on 1 rating
Google GmailYahoo MailHotmailAOL MailFacebookMySpaceOrkutTwitterLinkedInYahoo BookmarksGoogle BookmarksBlogger PostWordPressShare

Comments

You must be logged in to post a comment.

Name

Email

Website

Speak your mind

*
More in Miscellaneous (7 of 14 articles)


Blog from the American Heart Association's Epidemiology and Cardiovascular ...